Paris, November 6, 2023
- As part of the company’s strategy to accelerate in adult medical nutrition, Danone launches its first products in the adult Foods for Special Medical Purposes (aFSMP) category in China
- Fortimel is designed to meet the nutritional needs of patients recovering after surgery or non-communicable diseases like cancer and stroke and complements Danone’s existing offering of adult medical nutrition for tube-feeding
- The new range, which will be produced in China, brings together Danone’s longstanding expertise in medical nutrition and insights into the preferences and needs of Chinese patients
Danone today announces the launch of Fortimel, its first medical nutrition product in the adult Foods for Special Medical Purposes category in China. The launch is part of Danone’s strategy in China to leverage its scientific expertise across the life spectrum and further drive acceleration in adult medical nutrition.
As the Chinese population is aging and the incidence of chronic disease is on the rise it is becoming increasingly important to ensure adequate nutritional care upon discharge from the hospital too.
After discharge from hospital, medical nutrition like Fortimel can help to address the risk of malnutrition when nutritional requirements cannot be met through normal food alone.
Danone already provides its Nutrison and Peptisorb tube-feeding products for patients who cannot eat or swallow normally due to a condition or disease to 90% of the top tier hospitals in China, through Nutricia, providing specialist health services at city, provincial and national level.